{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T02:25:34Z","timestamp":1777861534849,"version":"3.51.4"},"reference-count":24,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:00:00Z","timestamp":1777507200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>People with Parkinson\u2019s Disease (PD) treated with dopamine agonists are at increased risk for developing impaired impulse control behavior. It has been suggested that patients tend to underreport problems with impaired impulse control, indicating that caregiver evaluations may be a helpful supplement to clinical assessment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To examine the agreement between evaluations of impaired impulse control provided by people with PD treated with dopamine agonists and by their caregivers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>People with PD and their caregivers independently completed the validated Questionnaire for Impulse-Compulsive Disorders in Parkinson\u2019s Disease-Rating Scale (QUIP-RS) and the Impulse Control Disorders and Related Conditions (ICDRC) questionnaire. Patient and caregiver assessment were compared statistically for total scores and subscores on both questionnaires.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Overall, patient and caregiver assessment on both the QUIP-RS and ICDRC showed no consistent systematic differences. Patients reported a slightly higher total ICDRC score and higher combined subscores for punding and dopamine dysregulation syndrome compared to their caregivers. Further, patient evaluations showed a wider range of responses for hypersexuality (QUIP-RS and ICDRC) and for gambling (ICDRC).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The assessment of impaired impulse control remains difficult, and our findings indicate that the role of caregiver evaluations is still uncertain.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fneur.2026.1791205","type":"journal-article","created":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T04:24:00Z","timestamp":1777523040000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Evaluating impulse control disorders in people with Parkinson\u2019s disease: agreement and added value of patient and caregiver reports"],"prefix":"10.3389","volume":"17","author":[{"given":"Sara C.","family":"Staubo","sequence":"first","affiliation":[{"name":"Department of Neurology, Oslo University Hospital","place":["Oslo, Norway"]},{"name":"Institute of Clinical Medicine, University of Oslo","place":["Oslo, Norway"]},{"name":"Department of Neurology, Akershus University Hospital","place":["Nordbyhagen, Norway"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabet","family":"St\u00f8rset","sequence":"additional","affiliation":[{"name":"Center for Psychopharmacology, Diakonhjemmet Hospital","place":["Oslo, Norway"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mathias","family":"Toft","sequence":"additional","affiliation":[{"name":"Department of Neurology, Oslo University Hospital","place":["Oslo, Norway"]},{"name":"Institute of Clinical Medicine, University of Oslo","place":["Oslo, Norway"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ingeborg H.","family":"Lie","sequence":"additional","affiliation":[{"name":"Department of Neurology, Oslo University Hospital","place":["Oslo, Norway"]},{"name":"Institute of Clinical Medicine, University of Oslo","place":["Oslo, Norway"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kirsti M. J.","family":"Alvik","sequence":"additional","affiliation":[{"name":"Unicare Fram Rehabilitation Centre","place":["Rykkinn, Norway"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P\u00e5l","family":"Jostad","sequence":"additional","affiliation":[{"name":"Ringen Rehabilitation Centre","place":["Moelv, Norway"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stein H.","family":"Tingvoll","sequence":"additional","affiliation":[{"name":"Ringen Rehabilitation Centre","place":["Moelv, Norway"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristina","family":"Rosqvist","sequence":"additional","affiliation":[{"name":"Division of Neurology, Department of Clinical Sciences, Lund University","place":["Lund, Sweden"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Per","family":"Odin","sequence":"additional","affiliation":[{"name":"Division of Neurology, Department of Clinical Sciences, Lund University","place":["Lund, Sweden"]},{"name":"Department of Neurology, Rehabilitation Medicine, Memory and Geriatrics, Sk\u00e5ne University Hospital","place":["Lund, Sweden"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erik Sveberg","family":"Dietrichs","sequence":"additional","affiliation":[{"name":"Institute of Clinical Medicine, University of Oslo","place":["Oslo, Norway"]},{"name":"Center for Psychopharmacology, Diakonhjemmet Hospital","place":["Oslo, Norway"]},{"name":"Institute for Experimental Medical Research, University of Oslo and Oslo University Hospital","place":["Oslo, Norway"]},{"name":"Experimental and Clinical Pharmacology, Institute of Medical Biology, UiT The Arctic University of Norway","place":["Troms\u00f8, Norway"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Espen","family":"Dietrichs","sequence":"additional","affiliation":[{"name":"Department of Neurology, Oslo University Hospital","place":["Oslo, Norway"]},{"name":"Institute of Clinical Medicine, University of Oslo","place":["Oslo, Norway"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,4,30]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1001\/archneurol.2010.65","article-title":"Impulse control disorders in Parkinson disease","volume":"67","author":"Weintraub","year":"2010","journal-title":"Arch Neurol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"e189","DOI":"10.1212\/wnl.0000000000005816","article-title":"Longitudinal analysis of impulse control disorders in Parkinson disease","volume":"91","author":"Corvol","year":"2018","journal-title":"Neurology"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1001\/archneur.63.7.969","article-title":"Association of Dopamine Agonist use with Impulse Control Disorders in Parkinson disease","volume":"63","author":"Weintraub","year":"2006","journal-title":"Arch Neurol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1006\/exnr.1996.6381","article-title":"New strategies with dopaminergic drugs: modified formulations of levodopa and novel agonists","volume":"144","author":"Goetz","year":"1997","journal-title":"Exp Neurol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1007\/s00228-011-1198-x","article-title":"Do Parkinson's disease patients disclose their adverse events spontaneously?","volume":"68","author":"Perez-Lloret","year":"2012","journal-title":"Eur J Clin Pharmacol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1136\/jnnp-2016-315277","article-title":"ICARUS study: prevalence and clinical features of impulse control disorders in Parkinson\u2019s disease","volume":"88","author":"Antonini","year":"2017","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1002\/mds.22571","article-title":"Validation of the questionnaire for impulsive-compulsive disorders in Parkinson's disease","volume":"24","author":"Weintraub","year":"2009","journal-title":"Mov Disord"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1002\/mds.24023","article-title":"Questionnaire for impulsive-compulsive disorders in Parkinson's disease\u2013rating scale","volume":"27","author":"Weintraub","year":"2012","journal-title":"Mov Disord"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1002\/mds.26016","article-title":"Clinical spectrum of impulse control disorders in Parkinson's disease","volume":"30","author":"Weintraub","year":"2015","journal-title":"Mov Disord"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/bs.irn.2017.04.006","article-title":"Impulse control and related disorders in Parkinson's disease","volume":"133","author":"Weintraub","year":"2017","journal-title":"Int Rev Neurobiol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1007\/s00702-018-1870-8","article-title":"Impulse control disorders in Parkinson\u2019s disease","volume":"125","author":"Marques","year":"2018","journal-title":"J Neural Transm (Vienna)"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1002\/mds.29700","article-title":"Management of Impulse Control and Related Disorders in Parkinson's disease: an expert consensus","volume":"39","author":"Debove","year":"2024","journal-title":"Mov Disord"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s10072-023-07006-1","article-title":"Impulse control disorders in Parkinson\u2019s disease: a retrospective analysis of 1824 patients in a 12-year period","volume":"45","author":"Gunduz","year":"2024","journal-title":"Neurol Sci"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1111\/ene.12646","article-title":"Impulse control disorders in Parkinson's disease: don't set your mind at rest by self-assessments","volume":"22","author":"Baumann-Vogel","year":"2015","journal-title":"Eur J Neurol"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"e16144","DOI":"10.1111\/ene.16144","article-title":"Dopamine agonist serum concentrations and impulse control disorders in Parkinson's disease","volume":"31","author":"Staubo","year":"2024","journal-title":"Eur J Neurol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1007\/s00415-024-12870-8","article-title":"Impulse control and correlation to dopamine agonist serum concentrations in people with Parkinson's disease","volume":"272","author":"Staubo","year":"2025","journal-title":"J Neurol"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/mds.26424","article-title":"MDS clinical diagnostic criteria for Parkinson's disease","volume":"30","author":"Postuma","year":"2015","journal-title":"Mov Disord"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1002\/mds.22340","article-title":"Movement Disorder Society-sponsored revision of the unified Parkinson's disease rating scale (MDS-UPDRS): scale presentation and clinimetric testing results","volume":"23","author":"Goetz","year":"2008","journal-title":"Mov Disord"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1212\/WNL.17.5.427","article-title":"Parkinsonism: onset, progression and mortality","volume":"17","author":"Hoehn","year":"1967","journal-title":"Neurology"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1002\/mds.20213","article-title":"Movement Disorder Society task force report on the Hoehn and Yahr staging scale: status and recommendations","volume":"19","author":"Goetz","year":"2004","journal-title":"Mov Disord"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1002\/mds.20844","article-title":"International multicenter pilot study of the first comprehensive self-completed nonmotor symptoms questionnaire for Parkinson's disease: the NMSQuest study","volume":"21","author":"Chaudhuri","year":"2006","journal-title":"Mov Disord"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/BF02260863","article-title":"The development and validation of a short measure of functioning and well being for individuals with Parkinson's disease","volume":"4","author":"Peto","year":"1995","journal-title":"Qual Life Res"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1007\/s00415-024-12865-5","article-title":"Impulse control disorders in Parkinson's disease: what's new?","volume":"272","author":"Marques","year":"2025","journal-title":"J Neurol"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1002\/mdc3.13128","article-title":"Does the country make a difference in impulse control disorders? A systematic review","volume":"8","author":"Parra-Diaz","year":"2021","journal-title":"Mov Disord Clin Pract"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2026.1791205\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T04:24:06Z","timestamp":1777523046000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2026.1791205\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,30]]},"references-count":24,"alternative-id":["10.3389\/fneur.2026.1791205"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2026.1791205","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,30]]},"article-number":"1791205"}}